Stock Performance and Market Context
On 13 Feb 2026, Quick Heal Technologies Ltd recorded an intraday low of Rs.173, representing a 3.41% drop during the trading session. This new low comes after the stock has declined for three consecutive days, resulting in a cumulative loss of 7.27% over this period. Despite this, the stock marginally outperformed the Software Products sector, which fell by 3.17% on the same day.
Quick Heal’s current price is significantly below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish momentum. The stock’s 52-week high was Rs.431.85, highlighting a steep decline of approximately 60% from that peak.
In comparison, the Sensex opened lower at 82,902.73, down 0.92% from the previous close, and is trading about 3.92% below its own 52-week high of 86,159.02. While the Sensex remains below its 50-day moving average, the 50DMA is still above the 200DMA, suggesting some underlying market resilience contrasting with Quick Heal’s performance.
Financial Performance and Valuation Concerns
Quick Heal Technologies Ltd’s financial metrics have shown deterioration over recent years. The company’s net sales have contracted at an annual rate of -1.02% over the last five years, while operating profit has declined sharply by -178.20% during the same period. These figures reflect challenges in sustaining growth and profitability.
The company’s quarterly results for December 2025 were largely flat, offering little indication of a turnaround. Additionally, the debtors turnover ratio for the half-year stood at a low 1.57 times, signalling slower collection cycles. Cash and cash equivalents were also at a modest Rs.6.84 crores, limiting liquidity buffers.
Non-operating income accounted for 155.65% of profit before tax in the quarter, suggesting that core business earnings remain under pressure. The stock’s earnings before interest, taxes, depreciation and amortisation (EBITDA) have been negative, further underscoring the risk profile of the company’s operations.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Long-Term and Recent Returns
The stock’s one-year return stands at -57.79%, a stark contrast to the Sensex’s positive 8.92% gain over the same period. This underperformance extends beyond the last year, with Quick Heal also lagging behind the BSE500 index over three years and the recent three-month period.
Such sustained negative returns reflect both the company’s financial challenges and market sentiment. The stock’s Mojo Score is 26.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, an upgrade from the previous Sell rating. This grading reflects the deteriorated fundamentals and valuation concerns.
Despite the weak returns, the company maintains a low average debt-to-equity ratio of zero, indicating minimal leverage. Promoters remain the majority shareholders, which may influence strategic decisions going forward.
Valuation and Risk Assessment
Quick Heal Technologies Ltd is currently trading at valuations considered risky relative to its historical averages. The decline in profits by 74.2% over the past year has contributed to this elevated risk perception. The stock’s market capitalisation grade is 3, indicating a smaller market cap relative to peers in the Software Products sector.
The combination of negative EBITDA, flat recent results, and weak sales growth has weighed heavily on investor confidence, reflected in the stock’s price action and technical indicators.
Quick Heal Technologies Ltd or something better? Our SwitchER feature analyzes this small-cap Software Products stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Environment
The Software Products sector has experienced a decline of 3.17% on the day Quick Heal hit its 52-week low, indicating broader sector pressures. However, Quick Heal’s outperformance relative to the sector by 1.8% on the day suggests some relative resilience despite the downtrend.
The broader market, represented by the Sensex, remains near its 52-week high, trading just under 4% below that level. This divergence between Quick Heal’s performance and the overall market highlights company-specific factors influencing the stock’s trajectory.
Summary of Key Metrics
To summarise, Quick Heal Technologies Ltd’s key metrics as of 13 Feb 2026 include:
- New 52-week low price: Rs.173
- Three-day consecutive decline: -7.27% cumulative loss
- Mojo Score: 26.0 (Strong Sell)
- Net sales growth (5 years): -1.02% annually
- Operating profit decline (5 years): -178.20%
- Debtors turnover ratio (HY): 1.57 times
- Cash and cash equivalents (HY): Rs.6.84 crores
- Non-operating income as % of PBT (Q): 155.65%
- One-year stock return: -57.79%
- Profit decline over one year: -74.2%
- Debt to equity ratio (average): 0
These figures collectively illustrate the challenges faced by Quick Heal Technologies Ltd in maintaining growth and profitability, which have been reflected in its share price performance.
Unlock special upgrade rates for a limited period. Start Saving Now →
